Lilly confirms date and conference call for third-quarter 2024 financial results announcementPRNewsWire • 10/16/24
This Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024The Motley Fool • 10/16/24
Survey reveals 8 in 10 Americans with ulcerative colitis struggle to find a public restroom during emergenciesPRNewsWire • 10/16/24
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?The Motley Fool • 10/16/24
FDA to Reconsider Removal of Lilly's Obesity Drug From Shortage ListZacks Investment Research • 10/15/24
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity DrugInvestors Business Daily • 10/14/24
Lilly reports one-year histologic outcomes in Phase 3 study of mirikizumab compared to ustekinumab for Crohn's diseasePRNewsWire • 10/14/24
8 Stocks Poised To Report Nvidia-Beating Profit Growth Any Day NowInvestors Business Daily • 10/09/24
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?The Motley Fool • 10/08/24
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and BayerZacks Investment Research • 10/08/24